Also, there were 39 out of 40 non–PDAC samples found no K-ras mutation except for one sample whose histologic diagnosis from EUS-FNA was pancreas neuroendocrine tumor. This evidence concerns the gene KRAS and pancreatic neuroendocrine tumor.